Case Report
Meningeal and Guillain–Barrè Syndrome in a Patient With Rheumatoid Arthritis Receiving Adalimumab Therapy
Síndrome meníngeo y síndrome de Guillain-Barrè en un paciente con artritis reumatoide tratado con adalimumab
Read
10940
Timeswas read the article
2605
Total PDF
8335
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 3 | 0 | 3 |
| 2025 5 | 140 | 46 | 186 |
| 2025 4 | 127 | 37 | 164 |
| 2025 3 | 96 | 28 | 124 |
| 2025 2 | 81 | 38 | 119 |
| 2025 1 | 83 | 34 | 117 |
| 2024 12 | 82 | 21 | 103 |
| 2024 11 | 50 | 36 | 86 |
| 2024 10 | 46 | 18 | 64 |
| 2024 9 | 57 | 18 | 75 |
| 2024 8 | 68 | 29 | 97 |
| 2024 7 | 63 | 28 | 91 |
| 2024 6 | 78 | 28 | 106 |
| 2024 5 | 62 | 30 | 92 |
| 2024 4 | 71 | 21 | 92 |
| 2024 3 | 65 | 34 | 99 |
| 2024 2 | 64 | 25 | 89 |
| 2024 1 | 51 | 22 | 73 |
| 2023 12 | 48 | 35 | 83 |
| 2023 11 | 50 | 21 | 71 |
| 2023 10 | 57 | 34 | 91 |
| 2023 9 | 88 | 42 | 130 |
| 2023 8 | 64 | 29 | 93 |
| 2023 7 | 44 | 23 | 67 |
| 2023 6 | 48 | 22 | 70 |
| 2023 5 | 42 | 18 | 60 |
| 2023 4 | 39 | 9 | 48 |
| 2023 3 | 94 | 29 | 123 |
| 2023 2 | 75 | 34 | 109 |
| 2023 1 | 39 | 19 | 58 |
| 2022 12 | 74 | 45 | 119 |
| 2022 11 | 100 | 24 | 124 |
| 2022 10 | 94 | 27 | 121 |
| 2022 9 | 74 | 31 | 105 |
| 2022 8 | 80 | 44 | 124 |
| 2022 7 | 77 | 47 | 124 |
| 2022 6 | 75 | 36 | 111 |
| 2022 5 | 65 | 39 | 104 |
| 2022 4 | 74 | 40 | 114 |
| 2022 3 | 97 | 50 | 147 |
| 2022 2 | 100 | 38 | 138 |
| 2022 1 | 73 | 30 | 103 |
| 2021 12 | 68 | 39 | 107 |
| 2021 11 | 70 | 43 | 113 |
| 2021 10 | 79 | 50 | 129 |
| 2021 9 | 70 | 51 | 121 |
| 2021 8 | 68 | 44 | 112 |
| 2021 7 | 87 | 33 | 120 |
| 2021 6 | 67 | 49 | 116 |
| 2021 5 | 91 | 49 | 140 |
| 2021 4 | 165 | 144 | 309 |
| 2021 3 | 133 | 33 | 166 |
| 2021 2 | 75 | 28 | 103 |
| 2021 1 | 62 | 27 | 89 |
| 2020 12 | 65 | 26 | 91 |
| 2020 11 | 79 | 22 | 101 |
| 2020 10 | 56 | 22 | 78 |
| 2020 9 | 64 | 19 | 83 |
| 2020 8 | 57 | 19 | 76 |
| 2020 7 | 47 | 14 | 61 |
| 2020 6 | 73 | 20 | 93 |
| 2020 5 | 71 | 25 | 96 |
| 2020 4 | 84 | 20 | 104 |
| 2020 3 | 27 | 11 | 38 |
| 2020 1 | 4 | 0 | 4 |
| 2019 9 | 6 | 0 | 6 |
| 2019 6 | 2 | 0 | 2 |
| 2019 3 | 2 | 0 | 2 |
| 2019 1 | 1 | 0 | 1 |
| 2018 5 | 4 | 1 | 5 |
| 2018 4 | 57 | 5 | 62 |
| 2018 3 | 145 | 8 | 153 |
| 2018 2 | 58 | 3 | 61 |
| 2018 1 | 36 | 4 | 40 |
| 2017 12 | 66 | 6 | 72 |
| 2017 11 | 47 | 4 | 51 |
| 2017 10 | 34 | 3 | 37 |
| 2017 9 | 59 | 6 | 65 |
| 2017 8 | 96 | 15 | 111 |
| 2017 7 | 71 | 16 | 87 |
| 2017 6 | 95 | 6 | 101 |
| 2017 5 | 75 | 10 | 85 |
| 2017 4 | 70 | 6 | 76 |
| 2017 3 | 68 | 28 | 96 |
| 2017 2 | 35 | 4 | 39 |
| 2017 1 | 39 | 10 | 49 |
| 2016 12 | 123 | 13 | 136 |
| 2016 11 | 87 | 8 | 95 |
| 2016 10 | 138 | 10 | 148 |
| 2016 9 | 127 | 4 | 131 |
| 2016 8 | 133 | 4 | 137 |
| 2016 7 | 92 | 12 | 104 |
| 2016 5 | 0 | 19 | 19 |
| 2016 4 | 1 | 16 | 17 |
| 2015 12 | 2 | 0 | 2 |
| 2015 10 | 0 | 17 | 17 |
| 2015 9 | 2 | 0 | 2 |
| 2015 8 | 2 | 0 | 2 |
| 2015 7 | 36 | 5 | 41 |
| 2015 6 | 62 | 5 | 67 |
| 2015 5 | 100 | 8 | 108 |
| 2015 4 | 69 | 10 | 79 |
| 2015 3 | 77 | 6 | 83 |
| 2015 2 | 64 | 6 | 70 |
| 2015 1 | 80 | 6 | 86 |
| 2014 12 | 64 | 9 | 73 |
| 2014 11 | 34 | 8 | 42 |
| 2014 10 | 68 | 8 | 76 |
| 2014 9 | 149 | 9 | 158 |
| 2014 8 | 112 | 10 | 122 |
| 2014 7 | 56 | 11 | 67 |
| 2014 6 | 84 | 7 | 91 |
| 2014 5 | 47 | 14 | 61 |
| 2014 4 | 45 | 7 | 52 |
| 2014 3 | 76 | 12 | 88 |
| 2014 2 | 52 | 6 | 58 |
| 2014 1 | 49 | 4 | 53 |
| 2013 12 | 35 | 6 | 41 |
| 2013 11 | 36 | 12 | 48 |
| 2013 10 | 45 | 10 | 55 |
| 2013 9 | 42 | 7 | 49 |
| 2013 8 | 51 | 9 | 60 |
| 2013 7 | 46 | 10 | 56 |
| 2013 6 | 49 | 8 | 57 |
| 2013 5 | 37 | 10 | 47 |
| 2013 4 | 32 | 14 | 46 |
| 2013 3 | 38 | 18 | 56 |
| 2013 2 | 35 | 15 | 50 |
| 2013 1 | 28 | 11 | 39 |
| 2012 12 | 30 | 13 | 43 |
| 2012 11 | 37 | 12 | 49 |
| 2012 10 | 14 | 10 | 24 |
| 2012 9 | 12 | 4 | 16 |
| 2012 7 | 1 | 0 | 1 |
| 2012 6 | 6 | 0 | 6 |
| 2012 5 | 4 | 0 | 4 |
| 2012 4 | 3 | 0 | 3 |
| 2012 3 | 5 | 0 | 5 |
| 2012 2 | 11 | 0 | 11 |
| 2012 1 | 13 | 0 | 13 |
| 2011 12 | 8 | 0 | 8 |
Show all
